Arch Therapeutics, Inc. Transition Agreements
1 Contracts & Agreements
- Amendment No. 1 to Transition Agreement, dated December 31, 2020, by and between Arch Therapeutics, Inc. and Richard Davis (Filed With SEC on May 3, 2021)
